Latest round: IPO. Nacho Abia joined Grifols as Chief Executive in 2024. Based in Barcelona, Spain.
Nacho Abia joined Grifols as Chief Executive in 2024. Grifols is a Barcelona-based Spanish pharma group specializing in plasma-derived therapeutics like immunoglobulins, operating the entire value chain from plasma collection to distribution. The company is planning an IPO for a minority stake in its US business to reduce debt and improve financial transparency.
Full founder directory · Investor directory · Company funding database · Fundraising library